Final-Program-ATS-2023-AP.vp

68

SUNDAY • MAY 21

P424 Establishment of the Alpha-1 Research Registry Analyzing Demographic and Participant Specific Characteristics/ M.P. Goldklang, New York, NY P425 Alpha-1 Antitrypsin Deficiency With Cutaneous Manifestation/ A. Shahid, St. Louis, MO P426 Impact of SARS-CoV2 Pandemic on Pragmatic Study Outcomes/ B.P. Yawn, Blaine, MN P427 Impact of One Vs. Two Walks on Responsiveness of the Incremental Shuttle Walk Test to Determine Functional Decline in a Tobacco Exposed Cohort/ C.A. Rapoza, Pittsburgh, PA P428 Association of Small Airway Dysfunction Parameters by Impulse Oscillometry With Lung Function Decline: A Based on ECOPD Cohort Study/ L. Lu, Guangzhou, China P429 PUMA Questionnaire in Combination With Peak Expiratory Flow Rate to Identify at-Risk COPD Subjects/ T.-H. Jeng, Taipei, Taiwan P430 Clinical, Radiologist-reported, and Quantitative Imaging Analysis-assessed Respiratory Disease in a Veteran Lung Cancer Screening Population/ G.H. Frobel, Boston, MA P431 Gender Bias in the Diagnosis of COPD in Smokers in a Community Setting/ I. Aiyer, Blairstown, NJ P432 Survey Results Among COPD Patients About Advanced Care Planning and Lung Disease Education Priorities/ D. Many, Charlottesville, VA P433 Neversmoker COPD: Does It Have a Different Clinical Course?/ S. Jo, Seoul, Korea, Republic of P434 A Social Media Listening Study to Understand the Key Focus Areas and Unmet Needs of Healthcare Professionals Around COPD/ A. Bhanja, London, United Kingdom P435 Sex and Age Related Differences in Clinical Profile and Outcomes in a Cohort of African Adults With COPD/ G.A. Amusa, Jos, Nigeria P436 Effectiveness of Lung Cancer Screening for Never Smoker COPD/ Y.J. Lee, Seongnam-SI, Korea, Republic of

P438 All That Coughs Is Not Corona: A Challenging Case Of Chronic Cough/ S. Biswas Roy, Phoenix, AZ P439 Is It Asthma?: A Rare Case of an Endobronchial Hamartoma/ K. Dhaliwal, Peoria, IL P440 Something in Your Lung: A Cough Caused by Hodgkin Lymphoma/ M. Heritage, Columbia, SC P441 Diffuse Large B Cell Lymphoma Masquerading As Chronic Cough In Pulmonary Clinic/ I. Budnick, Aurora, CO P442 Esophageal Rupture Secondary to Aggressive Coughing - Does It Happen?/ V.A. Persaud, Corpus Christi, TX P443 A Rigorous Persistent Cough Is Not to Be Ignored: A Case of Cough Induced Rib Fracture and Hemothorax in a 57 Year Old Male/ A.H.M. Aiken, Paterson, NJ P444 Impact of Productive and Dry Chronic Cough on Mortality in the Canadian Longitudinal Study on Aging (CLSA)/ I. Satia, Hamilton, Canada P445 Laryngeal Hypersensitivity Associated With Chronic Cough in Patients With Underlying Pulmonary Disease/ A. Taylor, Salt Lake City, UT P446 Nighttime Cough Frequency in Patients With Severe Asthma/ S. Nemala, Santa Clara, CA P447 No Such Thing as a COVID Cough/ M. Glass, Philadelphia, PA P448 A Novel Deep Learning Algorithm to Detect Cough and Throat Clearing Events Using Computer Aided Auscultation (cough-caae)/ H.A.H. Albitar, Rochester, MN P449 Development and Validation of the Mayo Clinic Cough Hypersensitivity Questionnaire (MACHS-Q)/ H.A.H. Albitar, Rochester, MN P450 A Randomized, Double-blind, Placebo Controlled, Dose Escalation Phase 2 Study Evaluating the Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough/ H.A.H. Albitar, Rochester, MN P451 Unexplained Chronic Cough: Review of Clinical Characteristics and Response to Pregabalin Therapy/ M.D. Saint-Pierre, Ottawa, Canada P452 A Phase 3b Trial of Gefapixant, A P2X3-receptor Antagonist, in Women With Chronic Cough and Stress Urinary Incontinence/ S.S. Birring, London, United Kingdom Comparative Analysis of Cough Counts, SpO2, and Patient-Reported Symptoms in Clinical Management/ G. Fann, Santa Clara, CA P453 Remote Monitoring of Pulmonary Patients: A

CLINICAL THEMATIC POSTER SESSION

A42

CHRONIC COUGH: CUTTING EDGE CLINICAL STUDIES AND CASE REPORTS

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area D, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

ATS 2023 • Washington, DC